Takayuki Chikata, Wayne Paes, Nozomi Kuse, Thomas Partridge, Hiroyuki Gatanaga, Yu Zhang, Kimiko Kuroki, Katsumi Maenaka, Nicola Ternette, Shinichi Oka, Persephone Borrow, and Masafumi Takiguchi, Impact of micropolymorphism outside the peptide binding groove in the clinically-relevant allele HLA-C*14 on T cell responses in HIV-1 infection, J. Virol. 96: e00432-22, 2022
カテゴリー: Publications(JP)
Virological characteristics of the SARS-CoV-2 Omicron BA.2 spikeの研究がCellに発表されました(池田研/上野研・Cell)
Daichi Yamasoba#, Izumi Kimura#, Hesham Nasser#, Yuhei Morioka#, Naganori Nao#, Jumpei Ito#, Keiya Uriu#, Masumi Tsuda#, Jiri Zahradnik#, Kotaro Shirakawa, Rigel Suzuki, Mai Kishimoto, Yusuke Kosugi, Kouji Kobiyama, Teppei Hara, Mako Toyoda, Yuri L. Tanaka, Erika P. Butlertanaka, Ryo Shimizu, Hayato Ito, Lei Wang, Yoshitaka Oda, Yasuko Orba, Michihito Sasaki, Kayoko Nagata, Kumiko Yoshimatsu, Hiroyuki Asakura, Mami Nagashima, Kenji Sadamasu, Kazuhisa Yoshimura, Jin Kuramochi, Motoaki Seki, Ryoji Fujiki, Atsushi Kaneda, Tadanaga Shimada, Taka-aki Nakada, Seiichiro Sakao, Takuji Suzuki, Takamasa Ueno, Akifumi Takaori-Kondo, Ken J. Ishii, Gideon Schreiber, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Hirofumi Sawa, Akatsuki Saito*, Takashi Irie*, Shinya Tanaka*, Keita Matsuno*, Takasuke Fukuhara*, Terumasa Ikeda*, Kei Sato*. (#Equal contribution; *Corresponding author)
Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike. 2022
DOI: 10.1016/j.cell.2022.04.035
URL: https://www.cell.com/cell/fulltext/S0092-8674(22)00533-5
Identification and characterization of a novel enhancer in the HTLV-1 proviral genomeの研究がNature communications に発表されました。(佐藤研・Nature communications )
Host cellular RNA helicases regulate SARS-CoV-2 infectionの研究が、Journal of Virologyに発表されました。 (有海研・Journal of Virology)
HTLV-1 infection promotes excessive T-cell activation and malignant transformation into adult T-cell leukemia/lymphoma の研究が、Journal of Clinical Investigationに発表されました。(佐藤研・Journal of Clinical Investigation)
Benjy Jek Yang Tan, Kenji Sugata, Omnia Reda, Misaki Matsuo, Kyosuke Uchiyama, Paola Miyazato, Vincent Hahaut, Makoto Yamagishi, Kaoru Uchimaru, Yutaka Suzuki, Takamasa Ueno, Hitoshi Suzushima, Hiroo Katsuya, Masahito Tokunaga, Yoshikazu Uchiyama, Hideaki Nakamura, Eisaburo Sueoka, Atae Utsunomiya, Masahiro Ono and Yorifumi Satou
DOI:10.1172/JCI150472
M-Sec induced by HTLV-1 mediates an efficient viral transmissionの研究が、PLOS PATHOGENSに発表されました(鈴研, PLOS PATHOGENS )
Masateru Hiyoshi, Naofumi Takahashi, Youssef M. Eltalkhawy, Osamu Noyori, Sameh Lotfi, Jutatip Panaampon, Seiji Okada, Yuetsu Tanaka, Takaharu Ueno, Jun-ichi Fujisawa, Yuko Sato, Tadaki Suzuki, Hideki Hasegawa, Shinya Suzu, M-Sec induced by HTLV-1 mediates an efficient viral transmission, Plos Pathogens, 2021
DOI:org/ 10.1371/journal.ppat.1010126
Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681Rの研究が、Nature誌に掲載されました(池田研, Nature )
著者:齊藤暁#, 入江崇#, 鈴木理滋#, 前村忠#, Hesham Nasser#, 瓜生慧也#, 小杉優介#, 白川康
太郎, 貞升健志, 木村出海, 伊東潤平, 呉佳齊, 岩附研子, 伊藤睦美, 山吉誠也, Samantha Loeber,
津田真寿美, Lei Wang, 大園誠也, バトラー田中英里佳, 田中友理, 清水凌, 清水健太, 吉松組子,
川端涼子, 坂口剛正, 徳永研三, 吉田勲, 浅倉弘幸, 長島真美, 数馬安浩, 野村亮介, 堀澤欣史, 吉村
和久, 高折晃史, 今井正樹, The Genotype to Phenotype Japan (G2P-Japan) Consortium, 田中
伸哉*, 中川草*, 池田輝政*, 福原崇介*, 河岡義裕*, 佐藤佳*
(#Equal contribution; *Corresponding author)
熊大プレスリリース
HLA-B*35:01の発症促進効果に関与するT細胞の研究が、Journal of Virology誌に掲載されました(滝口研, Journal of Virology)
Nozomi Kuse,* Hayato Murakoshi,* Tomohiro Akahoshi,* Takayuki Chikata, Katherine L James, Hiroyuki Gatanaga, Sarah L Rowland-Jones, Shinichi Oka, and Masafumi Takiguchi (*equal contribution), Collaboration of a detrimental HLA-B*35:01 allele with HLA-A*24:02 in co-evolution of HIV-1 with T-cells leading to poorer clinical outcomes, J. Virol. 95: e01259-21, 2021
Naïve T cellからHIV-1特異的CD8+ T細胞の誘導に関する研究が、Journal of Virology誌に掲載されました(滝口研,Journal of Virology)
Nozomi Kuse, Tomohiro Akahoshi, and Masafumi Takiguchi, STING ligand-mediated priming of functional CD8+ T-cells specific for HIV-1 protective epitopes from naive T-cells, J. Virol. 95: e00699-21, 2021
新型コロナウイルスの変異株に有効な中和抗体についてCell Reportsで発表しました(松下研・Cell Reports)
新型コロナに感染して回復した症例から中和抗体を分離し、ウイルスへの強い結合活性をもった中和抗体が変異株へも有効であることを発表しました。
Resistance of SARS-CoV-2 variants to neutralization by antibodies induced in convalescent patients with COVID-19
Yu Kaku, Takeo Kuwata* Hasan Md Zahid, Takao Hashiguchi, Takeshi Noda, Noriko Kuramoto, Shashwata Biswas, Kaho Matsumoto, Mikiko Shimizu, Yoko Kawanami, Kazuya Shimura, Chiho Onishi, Yukiko Muramoto, Tateki Suzuki, Jiei Sasaki, Yoji Nagasaki, Rumi Minami, Chihiro Motozono, Mako Toyoda, Hiroshi Takahashi, Hiroto Kishi, Kazuhiko Fujii, Tsuneyuki Tatsuke, Terumasa Ikeda, Yosuke Maeda, Takamasa Ueno, Yoshio Koyanagi, Hajime Iwagoe, and Shuzo Matsushita*








